Sector ratings Bio-Rad Laboratories, Inc. NYSE

Stocks

Market Closed - NYSE 16:10:00 2026-08-20 EDT			5-day change	1st Jan Change
365.08 ^USD	+8.33%		+8.33%	+17.50%

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
ABBOTT LABORATORIES	202B	BBB
MEDTRONIC PLC	119B	BBB
CENCORA, INC.	61.78B	AA
HOYA CORPORATION	52.35B	AAA
BECTON, DICKINSON AND COMPANY	51.96B	A
DEXCOM, INC.	34.36B	BBB
MEDLINE INC.	30.44B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.87B	AA
TERUMO CORPORATION	24.07B	AA
STERIS PLC	23.19B	AAA	-
SARTORIUS STEDIM BIOTECH	21.71B	BBB
ZIMMER BIOMET HOLDINGS, INC.	19.26B	A
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.48B	A
SOLVENTUM CORPORATION	15.53B	BBB
BAXTER INTERNATIONAL INC.	13.7B	A
GLOBUS MEDICAL, INC.	11.29B	CCC
ALIGN TECHNOLOGY, INC.	11.34B	A
INSULET CORPORATION	10.09B	A
REPLIGEN CORPORATION	10.25B	AA
Average	39.6B	A
Weighted average by Cap.		A